460 related articles for article (PubMed ID: 33902239)
21. Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women.
Aoyama-Kikawa S; Fujita H; Hanley SJB; Kasamo M; Kikuchi K; Torigoe T; Matsuno Y; Tamakoshi A; Sasaki T; Matsuura M; Kato Y; Dong P; Watari H; Saito T; Sengoku K; Sakuragi N
Cancer Sci; 2018 Jun; 109(6):2003-2012. PubMed ID: 29660849
[TBL] [Abstract][Full Text] [Related]
22. Punch biopsy guided by both colposcopy and HR-HPV status is more efficient for identification of immediate high-grade squamous intraepithelial lesion or worse among HPV-infected women with atypical squamous cells of undetermined significance.
Ding Z; Li Y; Chen A; Song M; Zhang Y
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():32-36. PubMed ID: 27816739
[TBL] [Abstract][Full Text] [Related]
23. Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology.
Einstein MH; Martens MG; Garcia FA; Ferris DG; Mitchell AL; Day SP; Olson MC
Gynecol Oncol; 2010 Aug; 118(2):116-22. PubMed ID: 20488510
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Different HPV-based Strategies and Cytology in Routine Cervical Cancer Screening Programme in China: A Population-based Study.
Wang S; Li L; Yang J; Han N; Bao H; Wang HJ
Cancer Prev Res (Phila); 2022 Jan; 15(1):45-54. PubMed ID: 34556493
[TBL] [Abstract][Full Text] [Related]
25. Comparison of cytology, HPV DNA testing and HPV 16/18 genotyping alone or combined targeting to the more balanced methodology for cervical cancer screening.
Chatzistamatiou K; Moysiadis T; Moschaki V; Panteleris N; Agorastos T
Gynecol Oncol; 2016 Jul; 142(1):120-127. PubMed ID: 27126005
[TBL] [Abstract][Full Text] [Related]
26. Value of P16 expression in the triage of liquid-based cervical cytology with atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions.
Ma YY; Cheng XD; Zhou CY; Qiu LQ; Chen XD; Lü WG; Xie X
Chin Med J (Engl); 2011 Aug; 124(16):2443-7. PubMed ID: 21933584
[TBL] [Abstract][Full Text] [Related]
27. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
[TBL] [Abstract][Full Text] [Related]
28. Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study.
Cox JT; Castle PE; Behrens CM; Sharma A; Wright TC; Cuzick J;
Am J Obstet Gynecol; 2013 Mar; 208(3):184.e1-184.e11. PubMed ID: 23174289
[TBL] [Abstract][Full Text] [Related]
29. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
Bhatla N; Dar L; Patro AR; Kumar P; Kriplani A; Gulati A; Iyer VK; Mathur SR; Sreenivas V; Shah KV; Gravitt PE
Cancer Epidemiol; 2009 Dec; 33(6):446-50. PubMed ID: 19931499
[TBL] [Abstract][Full Text] [Related]
30. A cross-sectional study on HPV testing with type 16/18 genotyping for cervical cancer screening in 11,064 Chinese women.
Wu Q; Zhao X; Fu Y; Wang X; Zhang X; Tian X; Cheng B; Lu B; Yu X; Lan S; Lu W; Ma D; Cheng X; Xie X
Cancer Med; 2017 May; 6(5):1091-1101. PubMed ID: 28378404
[TBL] [Abstract][Full Text] [Related]
31. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
32. Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology.
Agorastos T; Chatzistamatiou K; Katsamagkas T; Koliopoulos G; Daponte A; Constantinidis T; Constantinidis TC;
PLoS One; 2015; 10(3):e0119755. PubMed ID: 25793281
[TBL] [Abstract][Full Text] [Related]
33. The application of BMRT-HPV viral load to secondary screening strategies for cervical cancer.
Duan L; Du H; Wang C; Huang X; Qu X; Shi B; Liu Y; Zhang W; Duan X; Wei L; Belinson JL; Wu R
PLoS One; 2020; 15(5):e0232117. PubMed ID: 32357165
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of colposcopy after the addition of human papillomavirus testing to the Turkish cervical cancer screening program.
Gunes AC; Ozgul N; Turkyılmaz M; Kara F; Unlu F; Ayhan A; Gultekin M
Cancer Med; 2023 Dec; 12(24):21751-21760. PubMed ID: 37994572
[TBL] [Abstract][Full Text] [Related]
35. [Effectiveness of Different Testing Strategies Applied for Cervical Cancer Screening in Shuangliu District, Chengdu City].
Zeng X; Li J; Kang LN; Yan LP; He Z; Liao GD; Xi MR; Chen MY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Sep; 53(5):896-903. PubMed ID: 36224694
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Triage Strategies for HPV-Positive Women: Canadian Cervical Cancer Screening Trial Results.
Isidean SD; Mayrand MH; Ramanakumar AV; Rodrigues I; Ferenczy A; Ratnam S; Coutlée F; Franco EL;
Cancer Epidemiol Biomarkers Prev; 2017 Jun; 26(6):923-929. PubMed ID: 28096198
[No Abstract] [Full Text] [Related]
37. Clinical Performance of Triage Strategies for Hr-HPV-Positive Women; A Longitudinal Evaluation of Cytology, p16/K-67 Dual Stain Cytology, and HPV16/18 Genotyping.
Stanczuk G; Currie H; Forson W; Baxter G; Lawrence J; Wilson A; Palmer T; Arbyn M; Cuschieri K
Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1492-1498. PubMed ID: 35511738
[TBL] [Abstract][Full Text] [Related]
38. Co-infection with trichomonas vaginalis increases the risk of cervical intraepithelial neoplasia grade 2-3 among HPV16 positive female: a large population-based study.
Yang M; Li L; Jiang C; Qin X; Zhou M; Mao X; Xing H
BMC Infect Dis; 2020 Sep; 20(1):642. PubMed ID: 32873233
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the effectiveness of high-risk human papilloma self-sampling test for cervical cancer screening in Bolivia.
Allende G; Surriabre P; Ovando N; Calle P; Torrico A; Villarroel J; Bossens M; Fontaine V; Rodriguez P
BMC Infect Dis; 2020 Apr; 20(1):259. PubMed ID: 32245369
[TBL] [Abstract][Full Text] [Related]
40. The clinical value of HPV genotyping in triage of women with high-risk-HPV-positive self-samples.
Ebisch RM; de Kuyper-de Ridder GM; Bosgraaf RP; Massuger LF; IntHout J; Verhoef VM; Heideman DA; Snijders PJ; Meijer CJ; van Kemenade FJ; Bulten J; Siebers AG; Bekkers RL; Melchers WJ
Int J Cancer; 2016 Aug; 139(3):691-9. PubMed ID: 26991464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]